Instem Plc (LON:INS) has been reiterated to Corporate in a report by N+1 Singer earlier today.
- Updated: September 19, 2016
N+1 Singer has reiterated Instem Plc(LON:INS) to Corporate in a report released on 9/19/2016.
Yesterday Instem Plc (LON:INS) traded 0.93% higher at 277.50GBX. INS’s 50-day average is 249.14GBX and its 200-day moving average is 232.48GBX. With the last stock close up 18.96% relative to the two hundred day moving average, compared to the Standard & Poor’s 500 Index which has decreased -0.01% over the same time period. 650 shares of Instem Plc traded, down from ann avg. volume of 1,888.
Instem Plc has a one-year low of 185.00GBX and a 52 week high of 282.00GBX. The company’s market capitalization is presently 0.0 GBX.
Brief Synopsis About Instem Plc (LON:INS)
Instem plc is a supplier of information technology (IT) applications to the early development healthcare market delivering solutions for data collection, management and analysis across the research and development continuum. The Company is engaged in Global Life Sciences operations. Its lead product suite, Provantis, is an application in the Early Development Safety Assessment (EDSA) market. The Provantis solution incorporates a suite of modules required for managing and recording EDSA studies, from receipt of the compound through to the automated assembly of statistical analyses and final reports. Its software allows scientific staff to collect, analyze and share data across the organization and externally. It also offers ALPHADAS, an early phase clinical software solution. The Company offers Centrus suite, which provides pre-built applications, and as well as the ability to utilize a range of business intelligence and analysis tools.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.